• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

PPARG Gene Record

  • Summary
  • Interactions
  • Claims
  • PPARG 5468 Druggable GenomeClinically Actionable

    Alternate Names:

    5468
    PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA
    PPARG
    CIMT1
    GLM1
    NR1C3
    PPARG1
    PPARG2
    PPARgamma
    601487
    9236
    ENSG00000132170
    OTTHUMG00000129764
    P37231
    Peroxisome proliferator-activated receptor gamma
    PPAR-gamma
    Nuclear receptor subfamily 1 group C member 3
    PA281
    PPARG_HUMAN
    PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPAR-GAMMA). [SOURCE:UNIPROT/SWISSPROT;ACC:P37231]
    T58921
    PPARG5

    Gene Info:

    Target Class Receptors
    Target Subclass Nuclear receptor
    Initial Gene Query NR1C3
    Counted Citations from 1950-2000 8212
    Human Readable Name NUCLEAR HORMONE RECEPTOR
    Target Main Class Receptors
    Human Readable Name DRUGGABLE GENOME
    Interpro Acc IPR000536
    Interpro Type Domain
    Interpro Short Name Nucl_hrmn_rcpt_lig-bd_core
    Uniprot Status Swiss-Prot
    Interpro Name Nuclear hormone receptor, ligand-binding, core
    Uniprot Evidence 1: Evidence at protein level
    Gene Biotype PROTEIN_CODING
    (15 More Sources)

    Gene Categories: Category Details

    NUCLEAR HORMONE RECEPTOR
    DRUGGABLE GENOME
    CLINICALLY ACTIONABLE

    Publications:

    Kuroda M et al., 2010, Phenolics from Glycyrrhiza glabra roots and their PPAR-gamma ligand-binding activity., Bioorg Med Chem
    Tanabe H et al., 2014, Retinoic acid receptor agonist activity of naturally occurring diterpenes., Bioorg Med Chem
    Fuhr L et al., 2015, Amorfrutins Are Natural PPARγ Agonists with Potent Anti-inflammatory Properties., J Nat Prod
    Chang F et al., 2007, Evolution of peroxisome proliferator-activated receptor agonists., Ann Pharmacother
    Rousseaux et al., 2005, Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma., J. Exp. Med.
    Linard et al., 2008, Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist., J. Pharmacol. Exp. Ther.
    Desreumaux et al., 2006, Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence., Aliment. Pharmacol. Ther.
    Schwab et al., 2008, PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells., Carcinogenesis
    Iacucci et al., 2010, Mesalazine in inflammatory bowel disease: a trendy topic once again?, Can. J. Gastroenterol.
    Tursi, 2009, Balsalazide in treating colonic diseases., Expert Opin Drug Metab Toxicol
    Piemontese L et al., 2015, Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175., Eur J Med Chem
    Choi J et al., 2010, 1,3-Diphenyl-1H-pyrazole derivatives as a new series of potent PPARγ partial agonists., Bioorg Med Chem
    Xiao B et al., 2012, Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists., Bioorg Med Chem
    Gathiaka S et al., 2013, Design, development and evaluation of novel dual PPARδ/PPARγ agonists., Bioorg Med Chem Lett
    Kharbanda C et al., 2014, Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents., Bioorg Med Chem Lett
    Nazreen S et al., 2014, Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression., Bioorg Med Chem Lett
    Festa C et al., 2012, Plakilactones from the marine sponge Plakinastrella mamillaris. Discovery of a new class of marine ligands of peroxisome proliferator-activated receptor γ., J Med Chem
    Usui S et al., 2005, Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2., Bioorg Med Chem Lett
    Kharbanda C et al., 2015, Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect., Bioorg Med Chem Lett
    Liu W et al., 2011, Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators., J Med Chem
    Gorczynski MJ et al., 2009, Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation., J Med Chem
    MacDonald ML et al., 2006, Identifying off-target effects and hidden phenotypes of drugs in human cells., Nat Chem Biol
    Kameda et al., 2000, [Rosiglitazone (BRL-49653)]., Nippon Rinsho
    Rieusset et al., 1999, Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes., Biochem. Biophys. Res. Commun.
    Johnson et al., 2000, Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation., J. Mol. Biol.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Su et al., 1999, Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro., Hybridoma
    Camp et al., 2000, Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone., Diabetes
    Bhurruth-Alcor Y et al., 2010, Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPAR alpha selective., Bioorg Med Chem Lett
    Blüher M et al., 2003, Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes., Diabetes Care
    Sugii et al., 2009, PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization., Proc. Natl. Acad. Sci. U.S.A.
    Spiegelman, 1998, PPAR-gamma: adipogenic regulator and thiazolidinedione receptor., Diabetes
    Willson et al., 1996, The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones., J. Med. Chem.
    Miyazaki et al., 2004, Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients., J. Clin. Endocrinol. Metab.
    Lehmann et al., 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)., J. Biol. Chem.
    Sato A et al., 2013, Synthesis and evaluation of 2,3-dinorprostaglandins: Dinor-PGD1 and 13-epi-dinor-PGD1 are peroxisome proliferator-activated receptor α/γ dual agonists., Bioorg Med Chem Lett
    Mora FD et al., 2006, Bioassay for the identification of natural product-based activators of peroxisome proliferator-activated receptor-gamma (PPARgamma): the marine sponge metabolite psammaplin A activates PPARgamma and induces apoptosis in human breast tumor cells., J Nat Prod
    Guh JH et al., 2010, Development of novel adenosine monophosphate-activated protein kinase activators., J Med Chem
    Wick M et al., 2002, Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth., Mol Pharmacol
    Hiep NT et al., 2012, Polyhydroxylated macrolides from Seimatosporium discosioides and their effects on the activation of peroxisome proliferator-activated receptor gamma., J Nat Prod
    Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
    Hoang MH et al., 2012, Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells., Bioorg Med Chem Lett
    Nhiem NX et al., 2011, Oleanane-type triterpene saponins from the bark of Aralia elata and their NF-κB inhibition and PPAR activation signal pathway., Bioorg Med Chem Lett
    Petrova et al., 1999, Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2., Proc. Natl. Acad. Sci. U.S.A.
    Kitamura et al., 1999, Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells., Jpn. J. Cancer Res.
    Demetri et al., 1999, Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma., Proc. Natl. Acad. Sci. U.S.A.
    Satoh et al., 1999, Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells., Biochem. Biophys. Res. Commun.
    Camp et al., 1999, PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes., FEBS Lett.
    Baek et al., 2003, Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity., J. Biol. Chem.
    Hong SS et al., 2012, Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes., Bioorg Med Chem Lett
    Egerod FL et al., 2005, Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo., Biomarkers
    Chakrabarti et al., 2003, Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models., Br. J. Pharmacol.
    Cavender et al., 2010, Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus., Am J Cardiovasc Drugs
    Kasuga J et al., 2008, SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail., Bioorg Med Chem Lett
    Tenenbaum et al., 2005, Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons., Cardiovasc Diabetol
    Gong L et al., 2012, Celecoxib pathways: pharmacokinetics and pharmacodynamics., Pharmacogenet Genomics
    Durgam GG et al., 2006, Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands., Bioorg Med Chem Lett
    Lallemand B et al., 2011, N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity., J Med Chem
    Li JL et al., 2012, PPAR-γ agonistic metabolites from the ascidian Herdmania momus., J Nat Prod
    Pferschy-Wenzig EM et al., 2014, Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma., J Nat Prod
    Ubukata M et al., 2007, Mycophenolic acid as a latent agonist of PPARgamma., Bioorg Med Chem Lett
    Iio A et al., 2012, Hesperetin upregulates ABCA1 expression and promotes cholesterol efflux from THP-1 macrophages., J Nat Prod
    Herken H et al., 2009, The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia., DNA Cell Biol
    Lee JH et al., 2015, Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats., J Pharm Sci
  • MBX-2044   PPARG

    Interaction Score: 1.53

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma modulator
    Direct Interaction yes
    Trial Name MBX-2044

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • CLX-0921   PPARG

    Interaction Score: 1.53

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • CHEMBL2178583   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22934537


    Sources:
    DTC

  • LICOFLAVANONE A   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • SHINFLAVANONE   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • GLABRONE   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • CHEMBL2208197   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23189988


    Sources:
    DTC

  • CHEMBL2178586   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22934537


    Sources:
    DTC

  • ECHINATIN   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • OMS405   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • CHEMBL2057864   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22819190


    Sources:
    DTC

  • GANCAONIN L   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • CHEMBL2208196   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23189988


    Sources:
    DTC

  • CHEMBL599165   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • CHEMBL2208195   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23189988


    Sources:
    DTC

  • CHEMBL202243   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16263282


    Sources:
    DTC

  • CHEMBL1833984   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21889336


    Sources:
    DTC

  • ATX08-001   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • BALAGLITAZONE   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    partial agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma partial agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • NETOGLITAZONE   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    agonist (activating)
    modulator

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma modulator
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • CHEMBL2178596   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22934537


    Sources:
    DTC

  • ALEGLITAZAR   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name aleglitazar, R1439
    Novel drug target Established target
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    10592235 20653327


    Sources:
    TdgClinicalTrial ChemblInteractions

  • KANZONOL X   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • EFATUTAZONE HYDROCHLORIDE   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Novel drug target Established target
    Trial Name CS-7017
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • RAGAGLITAZAR   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    16240504 12970088 10592235


    Sources:
    TTD

  • RIVOGLITAZONE   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • ELATOSIDE D   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21889336


    Sources:
    DTC

  • CHEMBL1834951   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21889336


    Sources:
    DTC

  • SEIMATOPOLIDE A   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22424300


    Sources:
    DTC

  • KANZONOL W   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • INT131   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    partial agonist (activating)
    modulator

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma modulator
    Direct Interaction yes
    Trial Name INT-131, AMG-131, T131

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • SHINPTEROCARPIN   PPARG

    Interaction Score: 1.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • TESAGLITAZAR   PPARG

    Interaction Score: 0.77

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    16168052


    Sources:
    ChemblInteractions TTD

  • DB959   PPARG

    Interaction Score: 0.77

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name DB-959
    Novel drug target Established target
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • NAVEGLITAZAR   PPARG

    Interaction Score: 0.77

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name LY519818 , LY818
    Novel drug target Established target
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • ARHALOFENATE   PPARG

    Interaction Score: 0.77

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma modulator

    PMIDs:
    17519293


    Sources:
    ChemblInteractions TTD

  • BALSALAZIDE   PPARG

    Interaction Score: 0.64

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name balsalazide disodium,Colazal, Giazo
    Novel drug target Established target

    PMIDs:
    16939423 20151072 18077625 19708827


    Sources:
    TdgClinicalTrial

  • PIOGLITAZONE   PPARG

    Interaction Score: 0.55

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name pioglitazone HCl,Actos
    Novel drug target Established target
    Trial Name pioglitazone/metformin,Actoplus Met, Competact

    PMIDs:
    12610044 21030263 24890090 15745794 16680159 20018750 9568680 8576907 11752352 15356026 7768881


    Sources:
    DTC TdgClinicalTrial TEND PharmGKB TTD

  • LOBEGLITAZONE   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    activator (activating)

    Interaction Info:

    PMIDs:
    25648999


    Sources:
    TTD

  • EFATUTAZONE   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Notes

    PMIDs:
    None found


    Sources:
    TALC

  • THIAZOLIDINEDIONE   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • GLITAZONE   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • METAGLIDASEN   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name metaglidasen, JNJ-39659100, MBX-102
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TECNAZENE   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • GLABROL   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20022509


    Sources:
    DTC

  • IMIGLITAZAR   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • GW501516   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name GW501516
    Novel drug target Established target

    PMIDs:
    23566516


    Sources:
    DTC TdgClinicalTrial

  • IPRODIONE   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • FENOFIBRIC ACID   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22579484 23566516


    Sources:
    DTC

  • FARGLITAZAR   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • MK-0533   PPARG

    Interaction Score: 0.51

    Interaction Types & Directionality:
    modulator

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma modulator

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • ROSIGLITAZONE   PPARG

    Interaction Score: 0.47

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name rosiglitazone + glimepiride,Avandaryl
    Novel drug target Established target
    Trial Name rosiglitazone maleate + metformin HCl,Ava/

    PMIDs:
    25497132 21030263 22819190 23273519 25442322 24890090 22934537 15745794 26384286 22070604 19719236 16680159 10707565 10548525 10764590 11752352 10475242 10871190


    Sources:
    DTC TdgClinicalTrial TEND

  • CIGLITAZONE   PPARG

    Interaction Score: 0.43

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    23566516 16643023 20170185 12391285


    Sources:
    DTC

  • ISOSILYBIN A   PPARG

    Interaction Score: 0.34

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    24597776


    Sources:
    DTC

  • PROSTAGLANDIN D2   PPARG

    Interaction Score: 0.34

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23566516


    Sources:
    DTC

  • INDEGLITAZAR   PPARG

    Interaction Score: 0.34

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor agonist

    PMIDs:
    10592235


    Sources:
    ChemblInteractions

  • ABIETIC ACID   PPARG

    Interaction Score: 0.34

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    24799257


    Sources:
    DTC

  • TREPROSTINIL   PPARG

    Interaction Score: 0.34

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TEND

  • TROGLITAZONE   PPARG

    Interaction Score: 0.29

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    10200320 10076568 10097144 10222233 10214942 11752352 12475986 22342624 16680159 22579484 22424300


    Sources:
    DTC ChemblInteractions TTD

  • PHENAMIPHOS   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MITOGLITAZONE   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name MSDC-0160
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • CHEMBL166112   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ETALOCIB   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • MURAGLITAZAR   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes
    Trial Name muraglitazar, BMS-298585

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • AVE0847   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • AMORFRUTIN A   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    25938459


    Sources:
    DTC

  • OXEGLITAZAR   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • BENSULIDE   PPARG

    Interaction Score: 0.26

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ROSIGLITAZONE MALEATE   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • PIOGLITAZONE HYDROCHLORIDE   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • PROCHLORAZ   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • SODELGLITAZAR   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • ALDICARB   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TRIFLOXYSTROBIN   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • DIMETHENAMID   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • FLUORODIFEN   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • FLUDIOXONIL   PPARG

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MESALAMINE   PPARG

    Interaction Score: 0.15

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Novel drug target Established target
    Trial Name MAX-002
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist

    PMIDs:
    15824083 18077625 16939423 18544567


    Sources:
    TdgClinicalTrial ChemblInteractions

  • CHEMBL434063   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    16680159


    Sources:
    DTC

  • OLSALAZINE SODIUM   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • CHLORFENAPYR   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MYCOPHENOLIC ACID   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17618115


    Sources:
    DTC

  • NALED   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BALSALAZIDE DISODIUM   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • FLUOXASTROBIN   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TETRADECYLTHIOACETIC ACID   PPARG

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20036122


    Sources:
    DTC

  • HESPERETIN   PPARG

    Interaction Score: 0.11

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22429094


    Sources:
    DTC

  • SULFASALAZINE   PPARG

    Interaction Score: 0.11

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name sulfasalazine,Azulfidine, Salazopyrin
    Novel drug target Established target

    PMIDs:
    15824083 18077625 16939423 18544567


    Sources:
    TdgClinicalTrial

  • 2-PHENYLPHENOL   PPARG

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROPYLPARABEN   PPARG

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ENOXOLONE   PPARG

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21888390


    Sources:
    DTC

  • METHOXYCHLOR   PPARG

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ZOLEDRONIC ACID   PPARG

    Interaction Score: 0.09

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • PSAMMAPLIN A   PPARG

    Interaction Score: 0.08

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16643023


    Sources:
    DTC

  • GLYBURIDE   PPARG

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    26384286


    Sources:
    DTC

  • PHENOLPHTHALEIN   PPARG

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • BARDOXOLONE METHYL   PPARG

    Interaction Score: 0.06

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma antagonist

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • LEVOTHYROXINE   PPARG

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • 3R14S-OCHRATOXIN A   PPARG

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PATULIN   PPARG

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • E319   PPARG

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PROPYLPYRAZOLETRIOL   PPARG

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • CHEMBL312032   PPARG

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • KEPONE   PPARG

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • CHEMBL184450   PPARG

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ROTENONE   PPARG

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • GW7647   PPARG

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18162399


    Sources:
    DTC

  • BENZBROMARONE   PPARG

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PHENOTHIAZINE   PPARG

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • GENTIAN VIOLET   PPARG

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • DICHLOROPHEN   PPARG

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • SPIRONOLACTONE   PPARG

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • RALOXIFENE HYDROCHLORIDE   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • METHYLTHIONINIUM CHLORIDE   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • APIGENIN   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • 9,10-PHENANTHRENEQUINONE   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ESTRADIOL   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • CELECOXIB   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22336956


    Sources:
    PharmGKB

  • OLANZAPINE   PPARG

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    19622037


    Sources:
    PharmGKB

  • ASPIRIN   PPARG

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • METHOTREXATE   PPARG

    Interaction Score: 0.0

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • Ensembl: ENSG00000132170

    • Version: 101_38

    Alternate Names:
    PPARG Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • TdgClinicalTrial: P37231

    • Version: January-2014

    Alternate Names:
    PPARG Gene Symbol

    Gene Info:
    Target Class Receptors
    Target Subclass Nuclear receptor

    Publications:

  • BaderLabGenes: PPARG

    • Version: February-2014

    Alternate Names:
    5468 Entrez Gene ID

    Gene Info:
    Initial Gene Query NR1C3
    Counted Citations from 1950-2000 8212

    Gene Categories:
    NUCLEAR HORMONE RECEPTOR

    Publications:

  • HopkinsGroom: P37231

    • Version: 11-September-2012

    Alternate Names:
    PPARG_HUMAN Uniprot Id
    ENSG00000132170 Ensembl Gene Id
    PPARG Uniprot Gene Name

    Gene Info:
    Interpro Acc IPR000536
    Interpro Type Domain
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    NUCLEAR HORMONE RECEPTOR, DRUGGABLE GENOME

    Publications:

  • RussLampel: ENSG00000132170

    • Version: 26-July-2011

    Alternate Names:
    ENSG00000132170 Ensembl Gene Id
    PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPAR-GAMMA). [SOURCE:UNIPROT/SWISSPROT;ACC:P37231] Description
    PPARG Display Id

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • TEND: P37231

    • Version: 01-August-2011

    Alternate Names:
    PPARG Gene Symbol
    P37231 Uniprot Accession
    ENSG00000132170 Ensembl Gene Id

    Gene Info:
    Target Subclass Nuclear receptor
    Target Main Class Receptors

    Publications:

  • PharmGKB: PPARG

    • Version: 18-August-2020

    Alternate Names:
    PA281 PharmGKB ID

    Gene Info:

    Publications:
    Herken H et al., 2009, The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia., DNA Cell Biol
    Blüher M et al., 2003, Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes., Diabetes Care
    Gong L et al., 2012, Celecoxib pathways: pharmacokinetics and pharmacodynamics., Pharmacogenet Genomics

  • DTC: PPARG

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Tanabe H et al., 2014, Retinoic acid receptor agonist activity of naturally occurring diterpenes., Bioorg Med Chem
    Li JL et al., 2012, PPAR-γ agonistic metabolites from the ascidian Herdmania momus., J Nat Prod
    Xiao B et al., 2012, Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists., Bioorg Med Chem

  • TALC: PPARG

    • Version: 12-May-2016

    Alternate Names:
    PPARG Gene Symbol

    Gene Info:

    Publications:

  • ChemblInteractions: NR1C3

    • Version: chembl_23

    Alternate Names:
    NR1C3 GENE_SYMBOL
    PPARG GENE_SYMBOL
    Peroxisome proliferator-activated receptor gamma UNIPROT

    Gene Info:

    Publications:

  • HingoraniCasas: ENSG00000132170

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000132170 Gene Symbol
    PPARG Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • GO: PPARG

    • Version: 01-February-2022

    Alternate Names:
    NR1C3 GO Gene Synonym

    Gene Info:

    Gene Categories:
    NUCLEAR HORMONE RECEPTOR

    Publications:

  • Tempus: PPARG

    • Version: 11-November-2018

    Alternate Names:
    PPARG Gene Symbol

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • dGene: PPARG

    • Version: 27-Jun-2013

    Alternate Names:
    5468 Gene ID
    CIMT1 dGene Synonym
    GLM1 dGene Synonym

    Gene Info:

    Gene Categories:
    NUCLEAR HORMONE RECEPTOR

    Publications:

  • TTD: Peroxisome proliferator-activated receptor gamma

    • Version: 2020.06.01

    Alternate Names:
    PPAR-gamma TTD Gene Abbreviation
    T58921 TTD Target ID

    Gene Info:

    Publications:

  • Pharos: PPARG

    • Version: 01-February-2022

    Alternate Names:
    Peroxisome proliferator-activated receptor gamma Gene Name
    P37231 UniProt ID

    Gene Info:

    Gene Categories:
    NUCLEAR HORMONE RECEPTOR

    Publications:

  • FoundationOneGenes: PPARG

    • Version: 03-September-2020

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • CarisMolecularIntelligence: PPARG

    • Version: 04-September-2020

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • Oncomine: PPARG

    • Version: v3

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21